Alphabet's GV Leads Funding in Gene Editing Company Verve Therapeutics
GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.
iQoo 3 With 64-Megapixel Quad Rear Camera Setup Gets TENAA Certification
The upcoming iQoo 3 flagship has received the TENAA certification, and per the latter's database, it will pack a quad rear camera setup with a 64-megapixel main snapper.
Comments
Post a Comment